"High Sustained Virologic Response (SVR) in Genotype 1 (G1) Null Responders to Peg-Interfeon alfa-2b (P) plus Ribavirin (R) When Treated with Boceprevir (Boc) Combination Therapy.""
it sure is! It will be interesting to compare SVR to telaprevir - particularly since this is a much more homogeneous population to compare across studies